Core Viewpoint - The article discusses the implementation of a strict registration system for the sale of key controlled drugs in retail pharmacies in Foshan, effective from August 1, as part of the city's pandemic prevention efforts [1][2]. Group 1: Regulatory Changes - The Foshan Market Supervision Administration has mandated that all retail pharmacies in the city must adhere to a registration reporting system for 47 types of key controlled drugs [1]. - The registration system requires customers to provide personal information and undergo a verification process when purchasing specific medications related to symptoms of Chikungunya fever [1]. Group 2: Drug List and Compliance - The controlled drugs include common medications such as (compound) Ganmaoling, Xiao Chai Hu Granules, Lianhua Qingwen Capsules, (compound) Banlangen, Ibuprofen, and others [1]. - Pharmacies are instructed to assist vulnerable groups, such as the elderly, in completing the registration process while ensuring the confidentiality of personal information collected [1]. Group 3: Current Epidemic Situation - Guangdong Province reported 2,892 new local cases of Chikungunya fever from July 27 to August 2, with the majority of cases in Foshan [2]. - The epidemic's upward trend has shown signs of initial containment, particularly in the core area of Shunde, although risks from international cases and environmental factors remain [2].

Group 1 - The company, Jiutian Pharmaceutical, has responded to investor inquiries regarding its products for treating joint pain, which include Loxoprofen Sodium Gel Patches, Ketoprofen Gel Patches, Anti-inflammatory Pain Relief Plasters, and Ketoprofen Gel [1] - The company also offers antipyretic medications such as Loxoprofen Sodium Tablets and Loxoprofen Sodium Oral Solutions [1]